Motexafin gadolinium
- Generic Name
- Motexafin gadolinium
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C52H72GdN5O14
- CAS Number
- 246252-06-2
- Unique Ingredient Identifier
- 0BG5NE3APZ
- Background
Motexafin gadolinium is studied in the treatment of cancer by Pharmacyclics. It may make tumor cells more sensitive to radiation therapy, improve tumor images using magnetic resonance imaging (MRI), and kill cancer cells. It belongs to the family of drugs called metalloporphyrin complexes. Also called gadolinium texaphyrin.
- Indication
Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), lung cancer, and lymphoma (non-hodgkin's).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath